Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer

Ziyan Yang(Hebei Medical University), Wen‐Ming Cao(Unknown)
npj Breast Cancer
May 9, 2023
Cited by 8


Related Papers

No related papers found

Powered by citation graph analysis